𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa

✍ Scribed by NC van der Merwe; N Hamel; S-R Schneider; JP Apffelstaedt; JT Wijnen; WD Foulkes

Book ID
110889217
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
579 KB
Volume
81
Category
Article
ISSN
0009-9163

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

BRCA1 mutations in South African breast
BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families
✍ Michelle D. Reeves; Tali M. Yawitch; Nerina C. van der Merwe; Hester J. van den πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 89 KB πŸ‘ 1 views

## Abstract Germ‐line mutations within __BRCA1__ are responsible for different proportions of inherited susceptibility to breast/ovarian cancer, and the spectrum of mutations within this gene is often unique to certain populations. At this time, there have been no reports regarding the role of __BR

Prevalence of founder BRCA1 and BRCA2 mu
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 55 KB πŸ‘ 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation

A low frequency of non-founder BRCA1 mut
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families
✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b